相关实验视频
Updated: Jun 17, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
现型可塑性和癌症:一个系统生物学视角
Ayalur Raghu Subbalakshmi1, Sravani Ramisetty1, Atish Mohanty1
1Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.
癌细胞表现出混合表皮/介质细胞 (E/M) 现型,这对于转移和耐药性至关重要. 系统生物学方法是理解和针对新型癌症疗法这种可塑性的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 系统生物学 系统生物学
背景情况:
- 皮质到介质细胞的过渡 (EMT) 在发育,伤口愈合和癌症转移和纤维化等疾病中驱动表型可塑性.
- 癌症干细胞 (CSC) 过渡也会导致具有转移性影响的可塑性.
- 现型状态不是二进制的;癌细胞采用混合的上皮细胞/介质细胞 (E/M) 现型.
研究的目的:
- 探索混合E/M表型在癌症进展和治疗耐药性中的作用.
- 在理解癌细胞可塑性方面倡导系统生物学视角.
- 突出跨学科"团队医学"在识别新型癌症疗法方面的潜力.
主要方法:
- 审查和讨论关于EMT和癌症干细胞的现有文献.
- 整合系统生物学和团队医学方法的概念框架.
- 分析混合E/M表型在癌症中的影响.
主要成果:
- 混合E / M表型是瘤发病,转移和疾病进展的组成部分.
- 这些杂交表型在各种癌症中显著促进治疗耐药性.
- 现型可塑性,包括混合状态,在癌症治疗中构成了复杂的挑战.
结论:
- 系统生物学方法,结合跨学科的专业知识,对于推进我们对癌细胞可塑性的理解至关重要.
- 针对表型可塑性,特别是混合的EM状态,为新的治疗策略提供了有希望的途径.
- 团队医学对于开发全面的策略来打击癌症转移和抵抗至关重要.
更多相关视频
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
相关概念视频
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...